Dolsten Mikael — SEC insider filings

SEC reporting owner CIK 1437590. 33 insider filings on record with FilingPulse; latest filed 2026-09-09.

Transaction summary — filings shown

Covers all 33 filings on record, filed 2021-03-01 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PFIZER INC (PFE)President R&D17—13 legs · 123,566 sh · $6,152,19441
AGILENT TECHNOLOGIES, INC. (A)Director9—3 legs · 4,834 sh · $702,1556
ROCKET PHARMACEUTICALS, INC. (RCKT)Director4——6
Apellis Pharmaceuticals, Inc. (APLS)Director2——5
Karyopharm Therapeutics Inc. (KPTI)Director1——1

Insider filings — Dolsten Mikael

FiledFormIssuerReported transactionsSource
2026-09-094AGILENT TECHNOLOGIES, INC. (A)Sale (S): 634 @ $151.38EDGAR
2026-07-064ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 22,862 @ $0 · Grant/award (A): 64,860 (derivative) @ $0EDGAR
2026-06-024AGILENT TECHNOLOGIES, INC. (A)Sale (S): 1,600 @ $135.42EDGAR
2026-05-144Apellis Pharmaceuticals, Inc. (APLS)Code (U): 14,312 · Disposition to issuer (D): 14,312 · Disposition to issuer (D): 24,135 (derivative)EDGAR
2026-03-234AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 2,158 @ $111.75EDGAR
2026-03-034Apellis Pharmaceuticals, Inc. (APLS)Grant/award (A): 14,312 @ $0 · Grant/award (A): 24,135 (derivative) @ $20.96EDGAR
2025-12-034AGILENT TECHNOLOGIES, INC. (A)Sale (S): 2,600 @ $149.81EDGAR
2025-07-184ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 30,000 @ $0EDGAR
2025-04-244ROCKET PHARMACEUTICALS, INC. (RCKT)Other (J): 14,220 @ $0EDGAR
2025-03-184AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 1,819 @ $121.18EDGAR
2024-09-164PFIZER INC (PFE)Disposition to issuer (D): 137,760 (derivative) @ $0 · Grant/award (A): 137,760 (derivative) @ $0 · Disposition to issuer (D): 126,794 (derivative) @ $0 · Grant/award (A): 126,794 (derivative) @ $0EDGAR
2024-09-114ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 27,545 (derivative) @ $0 · Grant/award (A): 22,988 (derivative) @ $0EDGAR
2024-03-194AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 1,678 @ $147.48EDGAR
2024-02-294PFIZER INC (PFE)Tax withholding (F): 21,437 @ $27.04EDGAR
2024-02-284PFIZER INC (PFE)Grant/award (A): 214,880 (derivative) @ $0 · Grant/award (A): 189,867 (derivative) @ $0EDGAR
2024-02-274PFIZER INC (PFE)Tax withholding (F): 24,822 @ $27.76EDGAR
2023-12-194PFIZER INC (PFE)Code (I): 37,552 (derivative) @ $26.63EDGAR
2023-03-204AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 1,658 @ $136.82EDGAR
2023-02-284PFIZER INC (PFE)Tax withholding (F): 37,078 @ $41.75EDGAR
2023-02-244PFIZER INC (PFE)Tax withholding (F): 32,592 @ $42.38 · Grant/award (A): 137,760 (derivative) @ $0 · Grant/award (A): 119,894 (derivative) @ $0EDGAR
2022-11-094PFIZER INC (PFE)Option exercise (M): 50,938 @ $30.17 · Option exercise (M): 28,170 @ $38.71 · Option exercise (M): 127,146 (derivative) @ $0 · Option exercise (M): 133,430 (derivative) @ $0EDGAR
2022-05-124PFIZER INC (PFE)Sale (S): 200 @ $49.36 · Sale (S): 2,358 @ $49.34 · Sale (S): 2,891 @ $49.35 · Sale (S): 7,876 @ $49.33 · Sale (S): 18,562 @ $49.32 · Sale (S): 32,015 @ $49.31 · +1 moreEDGAR
2022-03-214AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 1,785 @ $136.82EDGAR
2022-03-044PFIZER INC (PFE)Option exercise (M): 62,022 @ $27.34 · Option exercise (M): 40,438 @ $38.71 · Option exercise (M): 127,674 (derivative) @ $0 · Option exercise (M): 158,331 (derivative) @ $0EDGAR
2022-03-014PFIZER INC (PFE)Tax withholding (F): 29,744 @ $47.72EDGAR
2022-02-254PFIZER INC (PFE)Tax withholding (F): 29,767 @ $46.87 · Grant/award (A): 126,794 (derivative) @ $0 · Grant/award (A): 111,516 (derivative) @ $0EDGAR
2021-12-214PFIZER INC (PFE)Option exercise (M): 71,187 @ $30.17 · Code (I): 25,219 (derivative) @ $59.48 · Option exercise (M): 152,085 (derivative) @ $0EDGAR
2021-11-154PFIZER INC (PFE)Option exercise (M): 76,135 @ $22.89 · Option exercise (M): 64,841 @ $27.34 · Option exercise (M): 58,572 @ $25.60 · Sale (S): 2,124 @ $50.34 · Sale (S): 2,301 @ $50.32 · Sale (S): 3,197 @ $50.29 · +8 moreEDGAR
2021-09-234AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 567 @ $172.44EDGAR
2021-05-214Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 23,900 (derivative) @ $0EDGAR
2021-03-024/APFIZER INC (PFE)Tax withholding (F): 28,271 @ $33.82EDGAR
2021-03-024PFIZER INC (PFE)Tax withholding (F): 23,841 @ $33.49EDGAR
2021-03-014PFIZER INC (PFE)Tax withholding (F): 28,271 @ $33.82 · Grant/award (A): 210,697 (derivative) @ $0 · Grant/award (A): 182,050 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-25 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1437590 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs